IncreMental Advantage performs technology and patent valuation analysis, with a primary focus on assessing early-stage technologies. Our valuation work spans practically every industry segment including semiconductors, pharmaceuticals, telecommunications, automotive, and many more. Our primary methodology for conducting our valuation assessments is Competitive Advantage Valuation (CAV). CAV is an extremely well-researched and thorough method of determining the value of technologies before they reach the market as well as before they generate revenues from licensing. IncreMental Advantage is one of the foremost authorities on utilizing CAV. We value individual technologies and patents as well as patent portfolios. For further information, please contact Scott Pearlman at 609-919-1895 ext. 111
or spearlman@incrementaladvantage.com. |
